Clinical Trial to Evaluate the Ingested, Space Occupying Hydrogel Capsules for Simple Obesity Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Simple Obesity
Interventions
DEVICE

Ingested, Space Occupying hydrogel capsules

During the treatment period (24 weeks after enrollment), Subjects should take four (4) capsules (Ingested, Space Occupying hydrogel capsules or placebo) with water every day 10\~20 minutes before lunch and dinner, and drink at least 500ml of water

DEVICE

placebo

During the treatment period (24 weeks after enrollment), Subjects should take four (4) capsules (Ingested, Space Occupying hydrogel capsules or placebo) with water every day 10\~20 minutes before lunch and dinner, and drink at least 500ml of water

Trial Locations (10)

100032

Beijing Friendship Hospital,Capital Medical University, Beijing

100043

Peking University Shougang Hospital, Beijing

100071

Beijing Shijitan Hospital, Capital Medical University, Beijing

110001

The First Affiliated Hospital of China Medical University, Shenyang

110004

Shengjing Hospital Of China Medical University, Shenyang

250012

QILU Hospital Of Shandong University, Jinan

300070

Tianjin Medical University General Hospital, Tianjin

410013

The Third XiangYa Hospital of Central South University, Changsha

471003

The First Affiliated Hospital of Henan University of Science & Technology, Luoyang

050023

The First Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

IMEIK Technology Development Co., Ltd.

INDUSTRY

NCT06530017 - Clinical Trial to Evaluate the Ingested, Space Occupying Hydrogel Capsules for Simple Obesity Treatment | Biotech Hunter | Biotech Hunter